title: [Prescription patterns and quality of information provided for consumers of benzodiazepines].
abstract: The long-time benzodiazepine use by a considerable part of the population and its adverse consequences such as somatic and cognitive side effects, interactions with other drugs and alcohol and its possible impairment of quality of life has provoked a critical discussion about the practice of prescribing benzodiazepine and the information provided by physicians. We therefore investigated these issues in admitted patients of a general hospital. All patients having been admitted to the department of Internal Medicine and taking benzodiazepine were asked by means of a semi-structured interview, which was repeated after 1 year. In 90% of later benzodiazepine discontinuers and in almost 50% of benzodiazepine continuers, tranquilisers were first prescribed during hospital admission. Only 2% of all patients estimated the information provided by the prescribing physicians as satisfying and about 2/3 reported that they did not get any information at all. 66% of all patients were informed about dependency risks. This information was mainly provided by pharmacies, friends and patient information leaflets; only about 20% of all patients were informed by the prescribing physician. Guidelines for tranquiliser prescription only seem to have a poor impact on the clinical practice. The education of physicians about the risks of low-dose dependencies and especially about complementary therapy methods needs to be improved.
authors.affiliation: Universitätsklinik für Psychiatrie, Währinger Gürtel 18-20, A-1090 Wien. karin.gutierrez@akh-wien.ac.at
authors.forename: K
authors.initials: K
authors.lastname: Gutiérrez-Lobos
authors.forename: S
authors.initials: S
authors.lastname: Fröhlich
authors.forename: S
authors.initials: S
authors.lastname: Quiner
authors.forename: C
authors.initials: C
authors.lastname: Haring
authors.forename: C
authors.initials: C
authors.lastname: Barnas
mesh_terms: D014151:Anti-Anxiety Agents / Q000009:adverse effects; D001317:Austria; D001569:Benzodiazepines / Q000009:adverse effects; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D017408:Guidelines as Topic; D006769:Hospitals, General; D006801:Humans; D010353:Patient Education as Topic; D011788:Quality of Life
chemical_list: D014151:Anti-Anxiety Agents; D001569:Benzodiazepines